Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL725848 | 0.94 | TSHR (0.36) | ESR1TSHRGAAMAPTKDM4E | |
| Hydrochloric Acid SCHEMBL7930504 | 0.91 | CYP3A4 (0.35) | ESR1TSHRGAAKMT2ACYP3A4 | |
| SCHEMBL26281354 | 0.84 | GAA (0.37) | ESR1GAAMAPTKMT2ACYP3A4 | |
| SCHEMBL9403425 | 0.84 | CYP3A4 (0.55) | TSHRGAAMAPTKMT2AALDH1A1 | |
| SCHEMBL20457103 | 0.80 | ALDH1A1 (0.36) | ESR1GAAALDH1A1 | |
| SCHEMBL12817837 | 0.78 | — | — | |
| SCHEMBL171114 | 0.78 | ACP1 (0.34) | ESR1ALDH1A1CRHR1 | |
| SCHEMBL17637576 | 0.78 | ESR1 (0.31) | ESR1MAPT | |
| SCHEMBL10934408 | 0.78 | — | — | |
| SCHEMBL25001764 | 0.78 | ESR1 (0.33) | ESR1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0552223-B1 | USE OF BENZENE DERIVATIVES AS CHARGE TRANSFER MEDIATORS | NOVO NORDISK AS (DK) | 1996-07-17 | — | — | EP | claimed |
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | SICPA HOLDING SA (CH) | 2025-12-30 | — | — | US | disclosed |
| EP-4069806-B1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2025-04-16 | — | — | EP | disclosed |
| US-20240327736-A1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2024-10-03 | — | — | US | disclosed |
| US-12031098-B2 | Method of marking a petroleum hydrocarbon | SICPA HOLDING SA (CH) | 2024-07-09 | — | — | US | disclosed |
| EP-4069807-B1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2023-10-04 | — | — | EP | disclosed |
| US-20230103579-A1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2023-04-06 | — | — | US | disclosed |
| EP-4069806-A1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | Sicpa Holding SA (CH) | 2022-10-12 | — | — | EP | disclosed |
| EP-4069807-A1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | Sicpa Holding SA (CH) | 2022-10-12 | — | — | EP | disclosed |
| EP-0552223-B1 | USE OF BENZENE DERIVATIVES AS CHARGE TRANSFER MEDIATORS | NOVO NORDISK AS (DK) | 1996-07-17 | — | — | EP | disclosed |
| EP-0552223-A1 | USE OF BENZENE DERIVATIVES AS CHARGE TRANSFER MEDIATORS. | NOVO NORDISK AS (DK) | 1993-07-28 | — | — | EP | disclosed |
| WO-1992007263-A1 | USE OF BENZENE DERIVATIVES AS CHARGE TRANSFER MEDIATORS | NOVO NORDISK A/S (DK) | 1992-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | CYP4A11, CYP11B1, CYP11A1 | ESR1 483/4885TSHR 2195/4885GAA 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.